Clinical study of stonetouch far-infrared device on atopic dermatitis

Hyun Kyu Kim, Mi Kyung Park, Kui Young Park, Myeung Nam Kim, Gana Oh, Soo-Hong Seo, Hyo Hyun Ahn, Young Chul Kye, Beom Joon Kim

Research output: Contribution to journalArticle

Abstract

Background: Atopie dermatitis (AD) is associated with severe pruritus, but there are only a few effective treatment modalities. Previous studies have demonstrated that infrared light inhibited the development of atopic dermatitis. Objective: This study is to evaluate the efficacy and safety of StoneTouch infrared device in reducing pruritus associated with atopic dermatitis. Methods: A total of 92 patients with atopic dermatitis with mild to moderate AD were enrolled in the randomized single-blind, placebo-controlled study. Randomly assigned StoneTouch® or sham device was irradiated three times daily for 14 days trial. Efficacy was evaluated by visual analogue scales and investigator's assessments. Results: Pruritus scores using VAS evaluated by patients revealed greater improvement in the StoneTouch infrared treatment group. Assessment of treated skin lesion by physicians showed significant improvement of skin findings in treated group. Transient erythema and mild irritation on the treated site were reported in a few patients. These symptoms were diminished within 1-2 days of treatment. Conclusion: StoneTouch ® infrared device is safe and effective in reducing pruritus in patients with atopic dermatitis.

Original languageEnglish
Pages (from-to)874-879
Number of pages6
JournalKorean Journal of Dermatology
Volume50
Issue number10
Publication statusPublished - 2012 Oct 1

Fingerprint

Atopic Dermatitis
Pruritus
Equipment and Supplies
Dermatitis
Skin
Erythema
Visual Analog Scale
Therapeutics
Placebos
Research Personnel
Physicians
Safety
Light
Clinical Studies

Keywords

  • Atopic dermatitis
  • Far-infrared light therapy
  • Pruritus

ASJC Scopus subject areas

  • Dermatology

Cite this

Kim, H. K., Park, M. K., Park, K. Y., Kim, M. N., Oh, G., Seo, S-H., ... Kim, B. J. (2012). Clinical study of stonetouch far-infrared device on atopic dermatitis. Korean Journal of Dermatology, 50(10), 874-879.

Clinical study of stonetouch far-infrared device on atopic dermatitis. / Kim, Hyun Kyu; Park, Mi Kyung; Park, Kui Young; Kim, Myeung Nam; Oh, Gana; Seo, Soo-Hong; Ahn, Hyo Hyun; Kye, Young Chul; Kim, Beom Joon.

In: Korean Journal of Dermatology, Vol. 50, No. 10, 01.10.2012, p. 874-879.

Research output: Contribution to journalArticle

Kim, HK, Park, MK, Park, KY, Kim, MN, Oh, G, Seo, S-H, Ahn, HH, Kye, YC & Kim, BJ 2012, 'Clinical study of stonetouch far-infrared device on atopic dermatitis', Korean Journal of Dermatology, vol. 50, no. 10, pp. 874-879.
Kim HK, Park MK, Park KY, Kim MN, Oh G, Seo S-H et al. Clinical study of stonetouch far-infrared device on atopic dermatitis. Korean Journal of Dermatology. 2012 Oct 1;50(10):874-879.
Kim, Hyun Kyu ; Park, Mi Kyung ; Park, Kui Young ; Kim, Myeung Nam ; Oh, Gana ; Seo, Soo-Hong ; Ahn, Hyo Hyun ; Kye, Young Chul ; Kim, Beom Joon. / Clinical study of stonetouch far-infrared device on atopic dermatitis. In: Korean Journal of Dermatology. 2012 ; Vol. 50, No. 10. pp. 874-879.
@article{1a8f31d9a973429e83958933bcde4355,
title = "Clinical study of stonetouch far-infrared device on atopic dermatitis",
abstract = "Background: Atopie dermatitis (AD) is associated with severe pruritus, but there are only a few effective treatment modalities. Previous studies have demonstrated that infrared light inhibited the development of atopic dermatitis. Objective: This study is to evaluate the efficacy and safety of StoneTouch infrared device in reducing pruritus associated with atopic dermatitis. Methods: A total of 92 patients with atopic dermatitis with mild to moderate AD were enrolled in the randomized single-blind, placebo-controlled study. Randomly assigned StoneTouch{\circledR} or sham device was irradiated three times daily for 14 days trial. Efficacy was evaluated by visual analogue scales and investigator's assessments. Results: Pruritus scores using VAS evaluated by patients revealed greater improvement in the StoneTouch infrared treatment group. Assessment of treated skin lesion by physicians showed significant improvement of skin findings in treated group. Transient erythema and mild irritation on the treated site were reported in a few patients. These symptoms were diminished within 1-2 days of treatment. Conclusion: StoneTouch {\circledR} infrared device is safe and effective in reducing pruritus in patients with atopic dermatitis.",
keywords = "Atopic dermatitis, Far-infrared light therapy, Pruritus",
author = "Kim, {Hyun Kyu} and Park, {Mi Kyung} and Park, {Kui Young} and Kim, {Myeung Nam} and Gana Oh and Soo-Hong Seo and Ahn, {Hyo Hyun} and Kye, {Young Chul} and Kim, {Beom Joon}",
year = "2012",
month = "10",
day = "1",
language = "English",
volume = "50",
pages = "874--879",
journal = "Korean Journal of Dermatology",
issn = "0494-4739",
publisher = "Korean Dermatological Association",
number = "10",

}

TY - JOUR

T1 - Clinical study of stonetouch far-infrared device on atopic dermatitis

AU - Kim, Hyun Kyu

AU - Park, Mi Kyung

AU - Park, Kui Young

AU - Kim, Myeung Nam

AU - Oh, Gana

AU - Seo, Soo-Hong

AU - Ahn, Hyo Hyun

AU - Kye, Young Chul

AU - Kim, Beom Joon

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Background: Atopie dermatitis (AD) is associated with severe pruritus, but there are only a few effective treatment modalities. Previous studies have demonstrated that infrared light inhibited the development of atopic dermatitis. Objective: This study is to evaluate the efficacy and safety of StoneTouch infrared device in reducing pruritus associated with atopic dermatitis. Methods: A total of 92 patients with atopic dermatitis with mild to moderate AD were enrolled in the randomized single-blind, placebo-controlled study. Randomly assigned StoneTouch® or sham device was irradiated three times daily for 14 days trial. Efficacy was evaluated by visual analogue scales and investigator's assessments. Results: Pruritus scores using VAS evaluated by patients revealed greater improvement in the StoneTouch infrared treatment group. Assessment of treated skin lesion by physicians showed significant improvement of skin findings in treated group. Transient erythema and mild irritation on the treated site were reported in a few patients. These symptoms were diminished within 1-2 days of treatment. Conclusion: StoneTouch ® infrared device is safe and effective in reducing pruritus in patients with atopic dermatitis.

AB - Background: Atopie dermatitis (AD) is associated with severe pruritus, but there are only a few effective treatment modalities. Previous studies have demonstrated that infrared light inhibited the development of atopic dermatitis. Objective: This study is to evaluate the efficacy and safety of StoneTouch infrared device in reducing pruritus associated with atopic dermatitis. Methods: A total of 92 patients with atopic dermatitis with mild to moderate AD were enrolled in the randomized single-blind, placebo-controlled study. Randomly assigned StoneTouch® or sham device was irradiated three times daily for 14 days trial. Efficacy was evaluated by visual analogue scales and investigator's assessments. Results: Pruritus scores using VAS evaluated by patients revealed greater improvement in the StoneTouch infrared treatment group. Assessment of treated skin lesion by physicians showed significant improvement of skin findings in treated group. Transient erythema and mild irritation on the treated site were reported in a few patients. These symptoms were diminished within 1-2 days of treatment. Conclusion: StoneTouch ® infrared device is safe and effective in reducing pruritus in patients with atopic dermatitis.

KW - Atopic dermatitis

KW - Far-infrared light therapy

KW - Pruritus

UR - http://www.scopus.com/inward/record.url?scp=84868656732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868656732&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 874

EP - 879

JO - Korean Journal of Dermatology

JF - Korean Journal of Dermatology

SN - 0494-4739

IS - 10

ER -